Utah Retirement Systems Merck & Co., Inc. Transaction History

Utah Retirement Systems

$8.7 Billion
Q3 2024

A detailed history of Utah Retirement Systems transactions in Merck & Co., Inc. stock. As of the latest transaction made, Utah Retirement Systems holds 419,710 shares of MRK stock, worth $41.8 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

419,710

Previous 417,810 0.45%

Holding current value

$41.8 Million

Previous $51.7 Million 7.85%

% of portfolio

0.55%

Previous 0.62%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $211,185 - $245,043	1,900 Added 0.45%	419,710 $47.7 Million
Q2 2024 Aug 14, 2024	SELL	$123.8 - $132.96 $2.86 Million - $3.07 Million	-23,100 Reduced 5.24%	417,810 $51.7 Million
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $11,324 - $13,194	100 Added 0.02%	440,910 $58.2 Million
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $270,486 - $294,354	2,700 Added 0.62%	440,810 $48.1 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $205,900 - $228,660	2,000 Added 0.46%	438,110 $45.1 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $1.59 Million - $1.73 Million	-14,600 Reduced 3.24%	436,110 $50.3 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $144,116 - $160,804	1,400 Added 0.31%	450,710 $48 Million
Q4 2022 Feb 15, 2023	SELL	$87.44 - $112.11 $375,992 - $482,073	-4,300 Reduced 0.95%	449,310 $49.8 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $185,966 - $208,912	2,200 Added 0.49%	453,610 $39.1 Million
Q2 2022 Aug 16, 2022	SELL	$83.49 - $94.64 $66,792 - $75,712	-800 Reduced 0.18%	451,410 $41.2 Million
Q1 2022 May 13, 2022	SELL	$73.51 - $82.4 $551,325 - $618,000	-7,500 Reduced 1.63%	452,210 $37.1 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $79,508 - $99,594	1,100 Added 0.24%	459,710 $35.2 Million
Q3 2021 Nov 16, 2021	SELL	$71.68 - $78.83 $1.75 Million - $1.92 Million	-24,400 Reduced 5.05%	458,610 $34.4 Million
Q2 2021 Aug 16, 2021	SELL	$70.31 - $77.77 $168,744 - $186,648	-2,400 Reduced 0.49%	483,010 $37.6 Million
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $1.47 Million - $1.73 Million	-21,300 Reduced 4.2%	485,410 $37.4 Million
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $1.56 Million - $1.73 Million	21,700 Added 4.47%	506,710 $41.4 Million
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $234,176 - $265,440	3,200 Added 0.66%	485,010 $40.2 Million
Q2 2020 Aug 13, 2020	SELL	$70.42 - $80.13 $302,806 - $344,559	-4,300 Reduced 0.88%	481,810 $37.3 Million
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $6,336 - $8,782	-100 Reduced 0.02%	486,110 $37.4 Million
Q4 2019 Feb 12, 2020	SELL	$77.58 - $87.54 $279,288 - $315,144	-3,600 Reduced 0.73%	486,210 $44.2 Million
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $68,472 - $74,637	900 Added 0.18%	489,810 $41.2 Million
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $199,532 - $233,102	-2,857 Reduced 0.58%	488,910 $41 Million
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $149,109 - $170,068	-2,143 Reduced 0.43%	491,767 $40.9 Million
Q4 2018 Feb 08, 2019	SELL	$65.24 - $75.71 $91,336 - $105,993	-1,400 Reduced 0.28%	493,910 $37.7 Million
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $201,915 - $237,440	-3,500 Reduced 0.7%	495,310 $35.1 Million
Q2 2018 Aug 10, 2018	SELL	$50.83 - $59.72 $589,628 - $692,752	-11,600 Reduced 2.27%	498,810 $30.3 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $40,768 - $47,384	800 Added 0.16%	510,410 $27.8 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $356,178 - $425,316	6,900 Added 1.37%	509,610 $28.7 Million
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $29.5 Million - $31.7 Million	502,710	502,710 $32.2 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.

Account

Utah Retirement Systems Merck & Co., Inc. Transaction History